INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$22.22M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09CMCannon-Brookes Michael35B / 0S35 trades$11.72M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 198 insiders$2.81M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

74,191 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
DM
Deitzer John MichaelVP, CFO
ATKRAtkore Inc.
Tax withholding
F$52K
806 sh
Nov 18, 2025Nov 19, 2025
Page 1788 of 1855
← PrevNext →
traded Nov 18, 2025
+1d
SEC Form 4

Evidence

12
BS
Burton SpencerPresident and COO
ENSGENSIGN GROUP, INC
Open-market sale · 10b5-1 plan
SELL$398K
2,209 sh
Nov 18, 2025Nov 19, 2025
traded Nov 18, 2025
+1dSEC Form 4

Evidence

12
GC
Graham Kristiane CDirector
DOVDOVER Corp
Grant or award
A$175K
972 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

12
PW
Pregenzer John WCOO & President, Electrical
ATKRAtkore Inc.
Tax withholding
F$60K
917 sh
Nov 18, 2025Nov 19, 2025
traded Nov 18, 2025
+1dSEC Form 4

Evidence

11
BC
Banks Matthew C.VP, CAO
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
5,260 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

11
BC
Banks Matthew C.VP, CAO
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
1,048 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

11
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$21K
10.0K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

11
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M—
29.3K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

11
VC
van Es CharlesChief Sales Officer
COCOVita Coco Company, Inc.
Option exercise · 10b5-1 plan
M—
20.0K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

11
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Open-market sale · 10b5-1 plan
SELL$838K
40.0K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

11
Field DylanDirector, President & CEO, 10% Owner
FIGFigma, Inc.
Derivative conversion · 10b5-1 plan
C$112.99M
3.03M sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

10
TE
Tessari EbenCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Option exercise · 10b5-1 plan
M$57K
6,500 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

10
TE
Tessari EbenCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$26K
645 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

10
VC
van Es CharlesChief Sales Officer
COCOVita Coco Company, Inc.
Option exercise · 10b5-1 plan
M$204K
20.0K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

10
BJ
Burth JonathanChief Operating Officer
COCOVita Coco Company, Inc.
Option exercise · 10b5-1 plan
M$180K
17.7K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

10
BJ
Burth JonathanChief Operating Officer
COCOVita Coco Company, Inc.
Option exercise · 10b5-1 plan
M$204K
20.0K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
BB
Bunker Mathew BSENIOR VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$6,514
126 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
NK
Norrett KevinChief Business Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
14.3K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
3,966 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
3,966 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
8,000 sh
Nov 18, 2025Nov 19, 2025
traded Nov 18, 2025
+1dSEC Form 4

Evidence

9
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
5,400 sh
Nov 18, 2025Nov 19, 2025
traded Nov 18, 2025
+1dSEC Form 4

Evidence

9
DR
Diaz RichardDirector
HFFGHF Foods Group Inc.
Grant or award
A—
12.4K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
BB
Bunker Mathew BSENIOR VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M$12K
238 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
MS
Miller ShannonPresident
JJACOBS SOLUTIONS INC.
Option exercise
M—
2,222 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
YS
Yi StevenDirector, See Remarks
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$94K
8,000 sh
Nov 19, 2025Nov 19, 2025
traded Nov 19, 2025
+0dSEC Form 4

Evidence

9
WJ
Wenzel Brian J. Sr.See remarks
SYFSynchrony Financial
Grant or award
A$21K
294 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
BB
Bunker Mathew BSENIOR VP, OPERATIONS
MCHPMICROCHIP TECHNOLOGY INC
Tax withholding
F$3,464
67 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
MS
Miller ShannonPresident
JJACOBS SOLUTIONS INC.
Tax withholding
F$6,777
45 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
HA
Heino Mary AnneDirector, Executive Chair
LNTHLantheus Holdings, Inc.
Grant or award
A—
26.3K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
WC
Williams Ashbel CDirector
CCBGCAPITAL CITY BANK GROUP INC
Grant or award
A—
228 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
JD
Jedda DanCFO & COO
ROKUROKU, INC
Tax withholding · 10b5-1 plan
F$996K
10.3K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
KR
Krawczyk Joseph R IISR. VP, WW CLIENT ENGAGEMENT
MCHPMICROCHIP TECHNOLOGY INC
Option exercise
M—
393 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
AK
Audhya Paul K.CHIEF MEDICAL OFFICER
KALVKalVista Pharmaceuticals, Inc.
Option exercise
M—
4,028 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
GC
Gentleman CourtneySee remarks
SYFSynchrony Financial
Grant or award
A$5,356
76 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
SM
Schatz David MSr. VP, Sec'y & Gen. Counsel
ESEESCO TECHNOLOGIES INC
Grant or award
A—
761 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
GC
Gibson ChristopherDirector, Chief Executive Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$166K
40.0K sh
Nov 19, 2025Nov 19, 2025
traded Nov 19, 2025
+0dSEC Form 4

Evidence

9
MS
Miller ShannonPresident
JJACOBS SOLUTIONS INC.
Option exercise
M—
1,198 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence

9
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
6,700 sh
Nov 19, 2025Nov 19, 2025
traded Nov 19, 2025
+0dSEC Form 4

Evidence

9
SC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
9,913 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC Form 4

Evidence